|
MLLT4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.319000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.155000E-01 |
| Normal-vs-Stage2 |
3.136400E-01 |
| Normal-vs-Stage3 |
5.735600E-01 |
| Normal-vs-Stage4 |
9.844600E-01 |
| Stage1-vs-Stage2 |
2.390800E-01 |
| Stage1-vs-Stage3 |
3.939400E-01 |
| Stage1-vs-Stage4 |
8.986800E-01 |
| Stage2-vs-Stage3 |
5.128400E-01 |
| Stage2-vs-Stage4 |
3.252000E-01 |
| Stage3-vs-Stage4 |
5.946400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.653600E-01 |
| Normal-vs-AfricanAmerican |
2.406600E-01 |
| Normal-vs-Asian |
7.709200E-01 |
| Caucasian-vs-AfricanAmerican |
2.099400E-01 |
| Caucasian-vs-Asian |
7.778000E-01 |
| AfricanAmerican-vs-Asian |
1.918980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.423800E-01 |
| Normal-vs-Female |
9.045600E-01 |
| Male-vs-Female |
1.340000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.559600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.645600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.430200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.713800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.879400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.701700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.837200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.839200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.580200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.740000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.132400E-02 |
| Classical-VS-Follicular |
5.37100000030932E-07 |
| Classical-VS-Other |
1.376960E-01 |
| Classical-VS-Normal |
2.161400E-01 |
| Tall-VS-Follicular |
3.829800E-02 |
| Tall-VS-Other |
3.491000E-01 |
| Tall-VS-Normal |
5.414000E-01 |
| Follicular-VS-Other |
8.884400E-01 |
| Follicular-VS-Normal |
5.844800E-03 |
| Other-VS-Normal |
2.182200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.501600E-01 |
| Normal-vs-N1 |
9.465600E-01 |
| N0-vs-N1 |
3.225200E-01 |
|
|
